• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于估算低传能线密度辐射暴露所致实体癌风险的剂量及剂量率有效性因子的概率分布

Probability Distribution of Dose and Dose-Rate Effectiveness Factor for use in Estimating Risks of Solid Cancers From Exposure to Low-Let Radiation.

作者信息

Kocher David C, Apostoaei A Iulian, Hoffman F Owen, Trabalka John R

机构信息

*Oak Ridge Center for Risk Analysis, Inc., 102 Donner Drive, Oak Ridge, TN 37830; †Deceased.

出版信息

Health Phys. 2018 Jun;114(6):602-622. doi: 10.1097/HP.0000000000000838.

DOI:10.1097/HP.0000000000000838
PMID:29697512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5922807/
Abstract

This paper presents an analysis to develop a subjective state-of-knowledge probability distribution of a dose and dose-rate effectiveness factor for use in estimating risks of solid cancers from exposure to low linear energy transfer radiation (photons or electrons) whenever linear dose responses from acute and chronic exposure are assumed. A dose and dose-rate effectiveness factor represents an assumption that the risk of a solid cancer per Gy at low acute doses or low dose rates of low linear energy transfer radiation, RL, differs from the risk per Gy at higher acute doses, RH; RL is estimated as RH divided by a dose and dose-rate effectiveness factor, where RH is estimated from analyses of dose responses in Japanese atomic-bomb survivors. A probability distribution to represent uncertainty in a dose and dose-rate effectiveness factor for solid cancers was developed from analyses of epidemiologic data on risks of incidence or mortality from all solid cancers as a group or all cancers excluding leukemias, including (1) analyses of possible nonlinearities in dose responses in atomic-bomb survivors, which give estimates of a low-dose effectiveness factor, and (2) comparisons of risks in radiation workers or members of the public from chronic exposure to low linear energy transfer radiation at low dose rates with risks in atomic-bomb survivors, which give estimates of a dose-rate effectiveness factor. Probability distributions of uncertain low-dose effectiveness factors and dose-rate effectiveness factors for solid cancer incidence and mortality were combined using assumptions about the relative weight that should be assigned to each estimate to represent its relevance to estimation of a dose and dose-rate effectiveness factor. The probability distribution of a dose and dose-rate effectiveness factor for solid cancers developed in this study has a median (50th percentile) and 90% subjective confidence interval of 1.3 (0.47, 3.6). The harmonic mean is 1.1, which implies that the arithmetic mean of an uncertain estimate of the risk of a solid cancer per Gy at low acute doses or low dose rates of low linear energy transfer radiation is only about 10% less than the mean risk per Gy at higher acute doses. Data were also evaluated to define a low acute dose or low dose rate of low linear energy transfer radiation, i.e., a dose or dose rate below which a dose and dose-rate effectiveness factor should be applied in estimating risks of solid cancers.

摘要

本文进行了一项分析,以建立剂量与剂量率有效性因子的主观知识状态概率分布,用于在假设急性和慢性照射的线性剂量响应情况下,估算因暴露于低线性能量传递辐射(光子或电子)而导致实体癌的风险。剂量与剂量率有效性因子表示这样一种假设:对于低线性能量传递辐射RL,在低急性剂量或低剂量率下每Gy发生实体癌的风险与在较高急性剂量下每Gy的风险RH不同;RL估计为RH除以剂量与剂量率有效性因子,其中RH是根据对日本原子弹幸存者剂量响应的分析得出的。通过对所有实体癌或除白血病外的所有癌症的发病或死亡风险的流行病学数据进行分析,建立了一个表示实体癌剂量与剂量率有效性因子不确定性的概率分布,分析包括:(1)对原子弹幸存者剂量响应中可能的非线性进行分析,以估计低剂量有效性因子;(2)将辐射工作人员或公众因长期低剂量率暴露于低线性能量传递辐射而产生的风险与原子弹幸存者的风险进行比较,以估计剂量率有效性因子。使用关于应赋予每个估计值的相对权重的假设,将实体癌发病率和死亡率的不确定低剂量有效性因子和剂量率有效性因子的概率分布进行组合,以表示其与剂量与剂量率有效性因子估计的相关性。本研究中建立的实体癌剂量与剂量率有效性因子的概率分布的中位数(第50百分位数)和90%主观置信区间为1.3(0.47,3.6)。调和均值为1.1,这意味着在低急性剂量或低剂量率下,低线性能量传递辐射每Gy发生实体癌风险的不确定估计值的算术均值仅比在较高急性剂量下每Gy的平均风险低约10%。还对数据进行了评估,以确定低线性能量传递辐射的低急性剂量或低剂量率,即在估算实体癌风险时应应用剂量与剂量率有效性因子的剂量或剂量率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/5922807/73a2f8bd3b4b/nihms929154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/5922807/63ea834302ba/nihms929154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/5922807/73a2f8bd3b4b/nihms929154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/5922807/63ea834302ba/nihms929154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b4e/5922807/73a2f8bd3b4b/nihms929154f2.jpg

相似文献

1
Probability Distribution of Dose and Dose-Rate Effectiveness Factor for use in Estimating Risks of Solid Cancers From Exposure to Low-Let Radiation.用于估算低传能线密度辐射暴露所致实体癌风险的剂量及剂量率有效性因子的概率分布
Health Phys. 2018 Jun;114(6):602-622. doi: 10.1097/HP.0000000000000838.
2
Solid cancer incidence in atomic bomb survivors: 1958-1998.原子弹爆炸幸存者实体癌发病率:1958 - 1998年
Radiat Res. 2007 Jul;168(1):1-64. doi: 10.1667/RR0763.1.
3
Monte Carlo mixture model of lifetime cancer incidence risk from radiation exposure on shuttle and international space station.航天飞机和国际空间站辐射暴露所致终生癌症发病风险的蒙特卡洛混合模型
Mutat Res. 1999 Dec 6;430(2):327-35. doi: 10.1016/s0027-5107(99)00145-1.
4
Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations.低传能线密度辐射的相对生物效应与传能线密度相关性综述。
J Radiol Prot. 2009 Mar;29(1):5-21. doi: 10.1088/0952-4746/29/1/R01. Epub 2009 Feb 18.
5
Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?与体内辐射源电离辐射暴露相关的癌症风险是否高于日本原子弹幸存者?
Radiat Environ Biophys. 2007 Nov;46(4):299-310. doi: 10.1007/s00411-007-0122-3. Epub 2007 Jul 17.
6
Relationship between radiation exposure and risk of second primary cancers among atomic bomb survivors.原子弹爆炸幸存者的辐射暴露与第二原发性癌症风险之间的关系。
Cancer Res. 2010 Sep 15;70(18):7187-98. doi: 10.1158/0008-5472.CAN-10-0276.
7
Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor.低剂量率辐射流行病学研究中实体癌的风险与剂量率有效性因子
Int J Radiat Biol. 2017 Oct;93(10):1064-1078. doi: 10.1080/09553002.2017.1319090. Epub 2017 May 15.
8
Lung cancer mortality between 1950 and 1987 after exposure to fractionated moderate-dose-rate ionizing radiation in the Canadian fluoroscopy cohort study and a comparison with lung cancer mortality in the Atomic Bomb survivors study.加拿大荧光透视队列研究中,1950年至1987年间暴露于分次中等剂量率电离辐射后的肺癌死亡率,以及与原子弹幸存者研究中的肺癌死亡率比较。
Radiat Res. 1995 Jun;142(3):295-304.
9
Cancer and non-cancer effects in Japanese atomic bomb survivors.日本原子弹幸存者中的癌症及非癌症影响。
J Radiol Prot. 2009 Jun;29(2A):A43-59. doi: 10.1088/0952-4746/29/2A/S04. Epub 2009 May 19.
10
Low dose radiation risks for women surviving the a-bombs in Japan: generalized additive model.日本原子弹爆炸幸存者中女性的低剂量辐射风险:广义相加模型
Environ Health. 2016 Nov 24;15(1):112. doi: 10.1186/s12940-016-0191-3.

引用本文的文献

1
Radiation dose rate effects: what is new and what is needed?辐射剂量率效应:有哪些新发现和需求?
Radiat Environ Biophys. 2022 Nov;61(4):507-543. doi: 10.1007/s00411-022-00996-0. Epub 2022 Oct 15.
2
Low-Dose Extrapolation Factors Implied by Mortality and Incidence Data from the Japanese Atomic Bomb Survivor Life Span Study Data.低剂量外推因子隐含在日本原子弹幸存者寿命研究数据中的死亡率和发病率数据中。
Radiat Res. 2022 Dec 1;198(6):582-589. doi: 10.1667/RADE-22-00108.1.
3
Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses.

本文引用的文献

1
Risk of solid cancer in low dose-rate radiation epidemiological studies and the dose-rate effectiveness factor.低剂量率辐射流行病学研究中实体癌的风险与剂量率有效性因子
Int J Radiat Biol. 2017 Oct;93(10):1064-1078. doi: 10.1080/09553002.2017.1319090. Epub 2017 May 15.
2
Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.原子弹爆炸幸存者寿命研究中的实体癌发病率:1958 - 2009年
Radiat Res. 2017 May;187(5):513-537. doi: 10.1667/RR14492.1. Epub 2017 Mar 20.
3
DS02R1: Improvements to Atomic Bomb Survivors' Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses.
对个体剂量估算的早期低、中剂量稀疏电离辐射暴露人群癌症风险的评估。
Environ Int. 2022 Jan 15;159:106983. doi: 10.1016/j.envint.2021.106983. Epub 2021 Dec 24.
4
Parameter Values for Estimation of Internal Doses from Ingestion of Radioactive Fallout from Nuclear Detonations.估算核爆炸放射性沉降物摄入所致内照射剂量的参数值。
Health Phys. 2022 Jan 1;122(1):236-268. doi: 10.1097/HP.0000000000001493.
5
Methodological improvements to meta-analysis of low dose rate studies and derivation of dose and dose-rate effectiveness factors.低剂量率研究荟萃分析方法的改进及剂量和剂量率效应因子的推导。
Radiat Environ Biophys. 2021 Aug;60(3):485-491. doi: 10.1007/s00411-021-00921-x. Epub 2021 Jul 4.
6
Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study.低剂量辐射暴露与癌症风险关联:INWORKS 核工作人员研究与原子弹幸存者研究结果比较。
Radiat Environ Biophys. 2021 Mar;60(1):23-39. doi: 10.1007/s00411-020-00890-7. Epub 2021 Jan 21.
7
Adverse outcome pathways, key events, and radiation risk assessment.不良结局途径、关键事件和辐射风险评估。
Int J Radiat Biol. 2021;97(6):804-814. doi: 10.1080/09553002.2020.1853847. Epub 2020 Dec 16.
8
ProZES: the methodology and software tool for assessment of assigned share of radiation in probability of cancer occurrence.ProZES:用于评估癌症发生概率中分配辐射份额的方法和软件工具。
Radiat Environ Biophys. 2020 Nov;59(4):601-629. doi: 10.1007/s00411-020-00866-7. Epub 2020 Aug 26.
9
Dose limits for occupational exposure to ionising radiation and genotoxic carcinogens: a German perspective.职业性接触电离辐射和遗传毒性致癌物的剂量限值:德国的观点。
Radiat Environ Biophys. 2020 Mar;59(1):9-27. doi: 10.1007/s00411-019-00817-x. Epub 2019 Nov 1.
10
THE DOSE AND DOSE-RATE EFFECTIVENESS FACTOR (DDREF).剂量与剂量率有效性因子(DDREF)。
Health Phys. 2019 Jan;116(1):96-99. doi: 10.1097/HP.0000000000000958.
DS02R1:原子弹幸存者输入数据的改进、2002年剂量测定系统(DS02)的实施以及估计剂量的相应变化
Health Phys. 2017 Jan;112(1):56-97. doi: 10.1097/HP.0000000000000598.
4
Mortality from solid cancers other than lung, liver, and bone in relation to external dose among plutonium and non-plutonium workers in the Mayak Worker Cohort.马亚克工人队列中钚接触工人和非钚接触工人的实体癌(肺癌、肝癌和骨癌除外)死亡率与外部剂量的关系。
Radiat Environ Biophys. 2017 Mar;56(1):121-125. doi: 10.1007/s00411-016-0670-5. Epub 2016 Sep 30.
5
THE MAYAK WORKER DOSIMETRY SYSTEM (MWDS-2013): TREATMENT OF UNCERTAINTY IN MODEL PARAMETERS.
Radiat Prot Dosimetry. 2017 Nov 1;176(1-2):144-153. doi: 10.1093/rpd/ncw248.
6
Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS).职业性接触电离辐射导致癌症的风险:法国、英国和美国工人的回顾性队列研究(INWORKS)
BMJ. 2015 Oct 20;351:h5359. doi: 10.1136/bmj.h5359.
7
Solid Cancer Incidence in the Techa River Incidence Cohort: 1956-2007.捷恰河流域队列研究中实体癌的发病率:1956 - 2007年
Radiat Res. 2015 Jul;184(1):56-65. doi: 10.1667/RR14023.1. Epub 2015 Jun 29.
8
Cancer Mortality through 2005 among a Pooled Cohort of U.S. Nuclear Workers Exposed to External Ionizing Radiation.截至2005年美国暴露于外照射电离辐射的核工业工作人员合并队列中的癌症死亡率。
Radiat Res. 2015 Jun;183(6):620-31. doi: 10.1667/RR13988.1. Epub 2015 May 26.
9
Radiation effects on mortality from solid cancers other than lung, liver, and bone cancer in the Mayak worker cohort: 1948-2008.马亚克工人队列中1948 - 2008年辐射对除肺癌、肝癌和骨癌之外的实体癌死亡率的影响
PLoS One. 2015 Feb 26;10(2):e0117784. doi: 10.1371/journal.pone.0117784. eCollection 2015.
10
Comments on the DDREF estimate of the BEIR VII Committee.对BEIR VII委员会剂量与剂量率效应关系(DDREF)估计值的评论。
Health Phys. 2015 Mar;108(3):351-6. doi: 10.1097/HP.0000000000000189.